GeneDx Holdings Corp (WGS) Stock Analysis

Verdict: HOLD

Aggressive insider buying and elite 68% margins signal a fundamental floor despite the recent 49% earnings-related price collapse.

Investment score: 64/100

Analysis as of

Is GeneDx Holdings Corp stock worth reviewing? The TradeMates thesis

High-conviction speculative buy based on 68% gross margins and aggressive insider buying after a -49% earnings-driven washout.

7-factor investment score

GeneDx Holdings Corp opportunities and risks

What speaks for WGS

What speaks against WGS

Peers and competitors

Trailing-twelve-month ratios
TickerP/EP/SEV/EBITDAGross marginNet marginFCF yield
WGSn/a3.1xn/a68.3%-17.6%-2.1%
MD10.2x0.9x7.8x25.8%9.0%13.5%
ADUS17.3x1.2x11.1x32.5%6.9%7.9%
ASTH62.1x0.5x16.7x9.3%0.9%8.1%
AVAH6.2x0.7x9.7x32.7%10.4%8.3%
AGLn/a0.2xn/a-2.7%-6.4%-5.6%
Peer median10.2x0.7x9.7x25.8%6.9%8.1%

Frequently asked questions about GeneDx Holdings Corp (WGS)

Is WGS stock a good investment?

The TradeMates model rates GeneDx Holdings Corp as HOLD with an investment score of 64/100. High-conviction speculative buy based on 68% gross margins and aggressive insider buying after a -49% earnings-driven washout. This is algorithmic model output, not personal investment advice.

Is WGS stock a buy?

The TradeMates model verdict for WGS is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.